Document is current

Any future updates will be listed below

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

Crossref DOI link: https://doi.org/10.1186/s13023-017-0653-x

Published Online: 2017-06-02

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark